These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 38138149)

  • 41. Role of factor H binding protein in Neisseria meningitidis virulence and its potential as a vaccine candidate to broadly protect against meningococcal disease.
    McNeil LK; Zagursky RJ; Lin SL; Murphy E; Zlotnick GW; Hoiseth SK; Jansen KU; Anderson AS
    Microbiol Mol Biol Rev; 2013 Jun; 77(2):234-52. PubMed ID: 23699256
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Biology and pathogenesis of the evolutionarily successful, obligate human bacterium Neisseria meningitidis.
    Stephens DS
    Vaccine; 2009 Jun; 27 Suppl 2(Suppl 2):B71-7. PubMed ID: 19477055
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Fighting Neisseria meningitidis: past and current vaccination strategies.
    Piccini G; Torelli A; Gianchecchi E; Piccirella S; Montomoli E
    Expert Rev Vaccines; 2016 Nov; 15(11):1393-1407. PubMed ID: 27158988
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Evaluating the effect of targeted strategies as control tools for hypervirulent meningococcal C outbreaks: a case study from Tuscany, Italy, 2015 to 2016.
    Guzzetta G; Ajelli M; Miglietta A; Fazio C; Neri A; Merler S; Rezza G; Stefanelli P
    Euro Surveill; 2023 May; 28(19):. PubMed ID: 37166763
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Carriage rate of Neisseria meningitidis, antibiotic susceptibility pattern and associated risk factors among primary school children in Gondar town, Northwest Ethiopia.
    Tefera Z; Mekonnen F; Tiruneh M; Belachew T
    BMC Infect Dis; 2020 May; 20(1):358. PubMed ID: 32434569
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Impact of Meningococcal B (4CMenB) Vaccine on Pharyngeal Neisseria meningitidis Carriage Density and Persistence in Adolescents.
    McMillan M; Walters L; Sullivan T; Leong LEX; Turra M; Lawrence A; Koehler AP; Finn A; Andrews RM; Marshall HS
    Clin Infect Dis; 2021 Jul; 73(1):e99-e106. PubMed ID: 32447370
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Outbreaks of meningococcal B infection and the 4CMenB vaccine: historical and future perspectives.
    Whelan J; Bambini S; Biolchi A; Brunelli B; Robert-Du Ry van Beest Holle M
    Expert Rev Vaccines; 2015 May; 14(5):713-36. PubMed ID: 25603916
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Virulence evolution of the human pathogen Neisseria meningitidis by recombination in the core and accessory genome.
    Joseph B; Schwarz RF; Linke B; Blom J; Becker A; Claus H; Goesmann A; Frosch M; Müller T; Vogel U; Schoen C
    PLoS One; 2011 Apr; 6(4):e18441. PubMed ID: 21541312
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Broad vaccine protection against Neisseria meningitidis using factor H binding protein.
    Findlow J; Bayliss CD; Beernink PT; Borrow R; Liberator P; Balmer P
    Vaccine; 2020 Nov; 38(49):7716-7727. PubMed ID: 32878710
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Variation in the Neisseria meningitidis FadL-like protein: an evolutionary model for a relatively low-abundance surface antigen.
    Yero D; Vipond C; Climent Y; Sardiñas G; Feavers IM; Pajón R
    Microbiology (Reading); 2010 Dec; 156(Pt 12):3596-3608. PubMed ID: 20817647
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Genomic Surveillance of 4CMenB Vaccine Antigenic Variants among Disease-Causing Neisseria meningitidis Isolates, United Kingdom, 2010-2016.
    Rodrigues CMC; Lucidarme J; Borrow R; Smith A; Cameron JC; Moxon ER; Maiden MCJ
    Emerg Infect Dis; 2018 Apr; 24(4):673-682. PubMed ID: 29553330
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Development of the epidemiological situation in invasive meningococcal disease in the Czech Republic caused by emerging Neisseria meningitidis clone ET-15/37.
    Krízová P; Musílek M; Kalmusová J
    Cent Eur J Public Health; 1997 Dec; 5(4):214-8. PubMed ID: 9457424
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Human B Cell Responses to Dominant and Subdominant Antigens Induced by a Meningococcal Outer Membrane Vesicle Vaccine in a Phase I Trial.
    Rollier CS; Dold C; Marsay L; Linder A; Green CA; Sadarangani M; Norheim G; Derrick JP; Feavers IM; Maiden MCJ; Pollard AJ
    mSphere; 2022 Feb; 7(1):e0067421. PubMed ID: 35080470
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Meningococcal B Vaccine and Meningococcal Carriage in Adolescents in Australia.
    Marshall HS; McMillan M; Koehler AP; Lawrence A; Sullivan TR; MacLennan JM; Maiden MCJ; Ladhani SN; Ramsay ME; Trotter C; Borrow R; Finn A; Kahler CM; Whelan J; Vadivelu K; Richmond P
    N Engl J Med; 2020 Jan; 382(4):318-327. PubMed ID: 31971677
    [TBL] [Abstract][Full Text] [Related]  

  • 55. B Part of It protocol: a cluster randomised controlled trial to assess the impact of 4CMenB vaccine on pharyngeal carriage of
    Marshall HS; McMillan M; Koehler A; Lawrence A; MacLennan JM; Maiden MCJ; Ramsay M; Ladhani SN; Trotter C; Borrow R; Finn A; Sullivan T; Richmond P; Kahler CM; Whelan J; Vadivelu K
    BMJ Open; 2018 Jul; 8(7):e020988. PubMed ID: 29991629
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Demographic Features of Invasive Meningococcal Disease in Taiwan, 1993 to 2020, and Genetic Characteristics of Neisseria meningitidis Isolates, 2003 to 2020.
    Chiou CS; Liao YS; Chen BH; Lu MC; Hong YP; Wang YW; Teng RH
    Microbiol Spectr; 2022 Aug; 10(4):e0088222. PubMed ID: 35862973
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Neisseria meningitidis and meningococcal disease: recent discoveries and innovations.
    Read RC
    Curr Opin Infect Dis; 2019 Dec; 32(6):601-608. PubMed ID: 31567569
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Genetic Similarity of Gonococcal Homologs to Meningococcal Outer Membrane Proteins of Serogroup B Vaccine.
    Marjuki H; Topaz N; Joseph SJ; Gernert KM; Kersh EN; ; Wang X
    mBio; 2019 Sep; 10(5):. PubMed ID: 31506309
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The Impact of Nucleotide Sequence Analysis on Meningococcal Vaccine Development and Assessment.
    Maiden MCJ
    Front Immunol; 2018; 9():3151. PubMed ID: 30697213
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Whole-genome comparison of disease and carriage strains provides insights into virulence evolution in Neisseria meningitidis.
    Schoen C; Blom J; Claus H; Schramm-Glück A; Brandt P; Müller T; Goesmann A; Joseph B; Konietzny S; Kurzai O; Schmitt C; Friedrich T; Linke B; Vogel U; Frosch M
    Proc Natl Acad Sci U S A; 2008 Mar; 105(9):3473-8. PubMed ID: 18305155
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.